Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD | Market Cap | 8.31B -58.9% |
| Revenue (ttm) | 2.34B +1.3% |
| Net Income | 345.30M -6.8% |
| EPS | 5.27 -6.6% |
| Shares Out | 65.40M |
| PE Ratio | 24.13 |
| Forward PE | 25.73 |
| Dividend | 4.30 (3.38%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 389,156 |
| Open | 125.68 |
| Previous Close | 127.11 |
| Day's Range | 125.68 - 130.21 |
| 52-Week Range | 88.74 - 314.61 |
| Beta | 0.26 |
| Analysts | Hold |
| Price Target | 125.19 (-3.86%) |
| Earnings Date | Aug 18, 2026 |
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i... [Read more]
Financial Performance
In fiscal year 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for COH stock is "Hold." The 12-month stock price target is $125.19, which is a decrease of -3.86% from the latest price.
News
Cochlear Limited's Osia 3 Processor Receives FDA Approval
Cochlear Limited's Osia 3 Processor Receives FDA Approval
Better Hearing and Whole-Body Health: What to Know About MRI Access with Cochlear Implants
During Better Hearing and Speech Month, understanding MRI compatibility is an important part of long-term hearing care LONE TREE, Colo., May 29, 2026 /PRNewswire/ -- May is Better Hearing and Speech M...
MED-EL USA Presents Real World Clinical Insights to Support Tailored Hearing Solutions at the 2026 American Cochlear Implant Association Meeting
DURHAM, N.C.--(BUSINESS WIRE)-- #ACIA2026--Hearing implant leader MED-EL USA is announcing two upcoming symposia at CI2026, the annual meeting of the American Cochlear Implant Association (ACIA) in Ch...
Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact
Cochlear shares crashed nearly 41% on Wednesday in a record daily fall, after the Australian hearing implants maker slashed its forecast for annual earnings, citing weak trading conditions and uncert...
Cochlear Transcript: Trading update
Lower sales and profit are driven by weak demand in developed markets, Middle East disruptions, and China reimbursement changes. Strategic focus remains on medicalizing hearing loss and accelerating growth initiatives, with a wide guidance range reflecting ongoing uncertainty.
Cochlear Earnings release: Trading update
Cochlear released its earnings on April 21, 2026, summarizing the period's financial results.
From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis
Companies in Australia and New Zealand are beginning to signal the financial strain from the U.S.-Israeli war on Iran, as higher fuel prices stoke inflation, dent business and consumer confidence, and...
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
LONE TREE, Colo., Feb. 25, 2026 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic Scholarsh...
Cochlear Earnings Call Transcript: H1 2026
First half results were impacted by the Nexa launch, leading to a 2% revenue decline and 17% net profit margin, with strong second half growth expected. FX headwinds and competitive pressures affected margins and share, but restructuring and growth initiatives are underway.
Cochlear Quarterly report: H1 2026
Cochlear has published its H1 2026 quarterly earnings report on February 12, 2026.
Cochlear Slides: H1 2026
Cochlear has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 12, 2026.
Cochlear Earnings release: H1 2026
Cochlear released its H1 2026 earnings on February 12, 2026, summarizing the period's financial results.
Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to elig...
MRI 3T Cochlear Implant Market Poised for 9.96% CAGR Growth, North America Leads
Ottawa, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The global MRI 3T cochlear implant market size is calculated at USD 902.78 million in 2025 and is expected to reach around USD 2101.54 million by 2034, growi...
MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older
DURHAM, N.C.--(BUSINESS WIRE)-- #FDAapproval--FDA approves expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Cochlear Transcript: AGM 2025
The AGM covered strong financial results, ongoing R&D investment, and board renewal. Shareholders discussed dividends, global expansion, and risks from tariffs and healthcare funding. Voting on all resolutions proceeded smoothly, with results to be released to the ASX.
Cochlear Earnings Call Transcript: H2 2025
Revenue grew 4% year-over-year with strong Cochlear implant and emerging market growth, but services declined 10% due to U.S. consumer hesitancy and a smaller eligible base. The Nexa system launch and continued R&D investment support a positive outlook, though China pricing and U.S. uncertainty remain headwinds.
Cochlear Annual report: H2 2025
Cochlear has published its H2 2025 annual report on August 14, 2025.
Cochlear Slides: H2 2025
Cochlear has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 14, 2025.
Cochlear Earnings release: H2 2025
Cochlear released its H2 2025 earnings on August 14, 2025, summarizing the period's financial results.
Cochlear Launches World's First and Only Smart Cochlear Implant System
Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates. Sm...
Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users
DURHAM, N.C.--(BUSINESS WIRE)-- #audiology--Driven by a shared commitment to advancing hearing health, global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration t...
Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
NEW Baha® 7 Sound Processor: First in bone conduction to enable Bluetooth® LE Audio* and Auracast™ broadcast audio streaming capabilities1, 2. NEW Baha SoundBand ™ : Improved look and fitting options ...
Hearing Implants Global Strategic Business Report 2025: Market to Reach $4.9 Billion by 2030 - Increasing Adoption of Cochlear Implants Expands Opportunities
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Hearing Implants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Hearing Implants ...
Assessment of the $6.63 Billion Cochlear Implants Market, 2034: Emerging Markets, such as Asia-Pacific, Latin America and Africa, Present a Significant Growth Opportunity
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Cochlear Implants Market - A Global and Regional Analysis: Focus on Patient Type, End User, and Region - Analysis and Forecast, 2024-2034" report has be...